- Home
- CARV vs BCDA Comparison
CARV vs BCDA Comparison
Compare CARV & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARV
- BCDA
- Stock Information
- Founded
- CARV 1948
- BCDA N/A
- Country
- CARV United States
- BCDA United States
- Employees
- CARV N/A
- BCDA N/A
- Industry
- CARV Savings Institutions
- BCDA Biotechnology: Pharmaceutical Preparations
- Sector
- CARV Finance
- BCDA Health Care
- Exchange
- CARV Nasdaq
- BCDA Nasdaq
- Market Cap
- CARV 9.6M
- BCDA 10.1M
- IPO Year
- CARV 1994
- BCDA N/A
- Fundamental
- Price
- CARV $1.70
- BCDA $1.74
- Analyst Decision
- CARV
- BCDA Strong Buy
- Analyst Count
- CARV 0
- BCDA 1
- Target Price
- CARV N/A
- BCDA $25.00
- AVG Volume (30 Days)
- CARV 70.8K
- BCDA 634.2K
- Earning Date
- CARV 08-18-2025
- BCDA 08-11-2025
- Dividend Yield
- CARV N/A
- BCDA N/A
- EPS Growth
- CARV N/A
- BCDA N/A
- EPS
- CARV N/A
- BCDA N/A
- Revenue
- CARV $21,046,000.00
- BCDA N/A
- Revenue This Year
- CARV N/A
- BCDA N/A
- Revenue Next Year
- CARV N/A
- BCDA N/A
- P/E Ratio
- CARV N/A
- BCDA N/A
- Revenue Growth
- CARV N/A
- BCDA N/A
- 52 Week Low
- CARV $1.30
- BCDA $1.63
- 52 Week High
- CARV $3.20
- BCDA $4.66
- Technical
- Relative Strength Index (RSI)
- CARV 36.29
- BCDA 31.51
- Support Level
- CARV $2.25
- BCDA $1.65
- Resistance Level
- CARV $2.59
- BCDA $1.85
- Average True Range (ATR)
- CARV 0.22
- BCDA 0.12
- MACD
- CARV -0.09
- BCDA -0.06
- Stochastic Oscillator
- CARV 0.00
- BCDA 5.19
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).